Rapid Dose Therapeutics and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones
Uncategorized September 15, 2021
Ryan Allway September 15th, 2021 Uncategorized Pre-clinical testing has demonstrated manufacturing stability and statistically significant antibody production BURLINGTON, Ontario, September 15, 2021–(BUSINESS WIRE)–Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company“) (CSE: DOSE) and McMaster University (“McMaster“) are reporting a preliminary, yet significant milestone in the investigation of an... Read more
